-
Change in the cognitive functioning summary score from baseline to 6-month stage
Time frame: Baseline and 6-month stage
Cognitive functioning summary score is calculated as an average of rescaled scores in following tests: Montreal Cognitive Assessment (MoCA) total score, MoCA Verbal Fluency subtest total score, Sustained Attention to Response Task (SART; correct responses & reaction times), Flexible Attention Test (FAT) / Reaction Time subtest (reaction times) and Trail Making subtest (correct responses & reaction times from difference scores between B part and A part), Simon Task (correct responses & reaction times from difference scores between Incongruence part and Congruence part), and Wechsler Memory Scale III (WMS-III) / Digit Span subtest (total score) and Spatial Span subtest (total score). Raw scores are rescaled to a scale of 0-100 using min-max normalization [(x-min(x))/(max(x)-min(x))*100] across the measurement points. The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the speech production summary score from baseline to 6-month stage
Time frame: Baseline and 6-month stage
Speech production summary score is calculated as an average of percentage of correct responses (score/maximum value*100; range 0-100) in the following subtests of the Western Aphasia Battery (WAB): Conversational Question, Picture Description, Repetition, Object Naming, Word Fluency, Sentence Completion, and Responsive Speech. The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the upper-extremity motor function summary score from baseline to 6-month stage
Time frame: Baseline and 6-month stage
Upper-extremity motor function summary score is calculated as an average of percentage of correct responses (score/maximum value*100; range 0-100) in following tests: Action Research Arm Test (ARAT; total score), Box and Block Test (BBT; total score), and Purdue Pegboard Test (PPT; total score). The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the mood and quality of life summary score from baseline to 6-month stage
Time frame: Baseline and 6-month stage
Mood and quality of life summary score is calculated as an average of percentage scores (score/maximum value*100; range 0-100) in following self-report questionnaires: Patient-Reported Outcomes Measurement Information System (PROMIS) / Depression scale (total score), PROMIS / Anxiety scale (total score), and Stroke Impact Scale (SIS; total score). The scores of the PROMIS are reversed to align with the SIS scores. The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the attention summary score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Attention summary score is calculated as an average of rescaled scores in following tests: Sustained Attention to Response Task (SART; correct responses & reaction times), Flexible Attention Test (FAT) / Reaction Time subtest (reaction times) and Trail Making subtest (correct responses & reaction times from A part), and Simon Task (correct responses & reaction times from Congruence part). Raw scores are rescaled to a scale of 0-100 using min-max normalization [(x-min(x))/(max(x)-min(x))*100] across the measurement points. The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the executive function summary score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Executive function summary score is calculated as an average of rescaled scores in following tests: MoCA Verbal Fluency subtest total score, Flexible Attention Test (FAT) / Trail Making subtest (correct responses & reaction times from difference scores between B part and A part), and Simon Task (correct responses & reaction times from difference scores between Incongruence part and Congruence part). Raw scores are rescaled to a scale of 0-100 using min-max normalization [(x-min(x))/(max(x)-min(x))*100] across the measurement points. The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the working memory summary score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Working memory summary score is calculated as an average of percentage of correct responses (score/maximum value*100; range 0-100) in the Wechsler Memory Scale III (WMS-III) / Digit Span subtest (total score) and Spatial Span subtest (total score). The range of the summary score is 0-100 (higher score indicates better outcome).
-
Change in the MoCA total score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Montreal Cognitive Assessment (MoCA) total score (range 0-30, higher score indicates better outcome), measures general cognitive function.
-
Change in the MoCA Verbal Fluency subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Montreal Cognitive Assessment (MoCA) Verbal Fluency subtest score (phonemic fluency; min value: 0, max value: no upper limit; higher score indicates better outcome), measures executive functioning (cognitive flexibility).
-
Change in the SART correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Sustained Attention to Response Task (SART), number of correct responses (range 0-225, higher score indicates better outcome), measures sustained attention.
-
Change in the SART reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Sustained Attention to Response Task (SART), average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures sustained attention.
-
Change in the FAT Reaction Time subtest reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Reaction Time subtest, average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures selective attention & psychomotor speed.
-
Change in the FAT Trail Making subtest (A part) correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Trail Making subtest (A part), number of correct responses (range 0-24, higher score indicates better outcome), measures selective attention.
-
Change in the FAT Trail Making subtest (A part) reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Trail Making subtest (A part), average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures selective attention.
-
Change in the FAT Trail Making subtest (B part) correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Trail Making subtest (B part), number of correct responses (range 0-24, higher score indicates better outcome), measures executive function (set-shifting).
-
Change in the FAT Trail Making subtest (B part) reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Trail Making subtest (B part), average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures executive function (set-shifting).
-
Change in the FAT Trail Making subtest (difference between B part and A part) correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Trail Making subtest (difference between B part and A part), number of correct responses (range 0-24, lower score indicates better outcome), measures executive function (set-shifting).
-
Change in the FAT Trail Making subtest (difference between B part and A part) reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Flexible Attention Test (FAT) / Trail Making subtest (difference between B part and A part), average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures executive function (set-shifting).
-
Change in the Simon Task (Congruence part) correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Simon Task / Congruence part, number of correct responses (range 0-50, higher score indicates better outcome), measures selective attention.
-
Change in the Simon Task (Congruence part) reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Simon Task / Congruence part, average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures selective attention.
-
Change in the Simon Task (Incongruence part) correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Simon Task / Incongruence part, number of correct responses (range 0-50, higher score indicates better outcome), measures executive function (inhibition).
-
Change in the Simon Task (Incongruence part) reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Simon Task / Incongruence part, average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures executive function (inhibition).
-
Change in the Simon Task (difference between Incongruence part and Congruence part) correct responses from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Simon Task: Difference between Incongruence part and Congruence part, number of correct responses (range 0-50, lower score indicates better outcome), measures executive function (set-shifting).
-
Change in the Simon Task (difference between Incongruence part and Congruence part) reaction times from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Simon Task: Difference between Incongruence part and Congruence part, average reaction time (ms) across trials (scores do not have a fixed range, lower score indicates better outcome), measures executive function (set-shifting).
-
Change in the WMS-III Digit Span subtest (forward recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Digit Span subtest, forward recall score (range 0-16, higher score indicates better outcome), measures verbal working memory.
-
Change in the WMS-III Digit Span subtest (backward recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Digit Span subtest, backward recall score (range 0-14, higher score indicates better outcome), measures verbal working memory.
-
Change in the WMS-III Digit Span subtest (total score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Digit Span subtest, total score (range 0-30, higher score indicates better outcome), measures verbal working memory.
-
Change in the WMS-III Spatial Span subtest (forward recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Spatial Span subtest, forward recall score (range 0-16, higher score indicates better outcome), measures visuospatial working memory.
-
Change in the WMS-III Spatial Span subtest (backward recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Spatial Span subtest, backward recall score (range 0-16, higher score indicates better outcome), measures visuospatial working memory.
-
Change in the WMS-III Spatial Span subtest (total score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Spatial Span subtest, total score (range 0-32, higher score indicates better outcome), measures visuospatial working memory.
-
Change in the WMS-III Word Lists subtest (1st learning trial score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Word Lists subtest, 1st learning trial score (range 0-12, higher score indicates better outcome), measures verbal memory & learning
-
Change in the WMS-III Word Lists subtest (learning trials change score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Word Lists subtest, change score from the 1st to 4th learning trial (range 0-12, higher score indicates better outcome), measures verbal memory & learning.
-
Change in the WMS-III Word Lists subtest (learning trials total score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Word Lists subtest, total score over 4 learning trials (range 0-48, higher score indicates better outcome), measures verbal memory & learning.
-
Change in the WMS-III Word Lists subtest (learning trials recognition score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Word Lists subtest, recognition (old-new) score after 4 learning trials (range 0-24, higher score indicates better outcome), measures verbal memory & learning.
-
Change in the WMS-III Word Lists subtest (delayed recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Word Lists subtest, delayed recall score (range 0-12, higher score indicates better outcome), measures verbal memory & learning.
-
Change in the WMS-III Word Lists subtest (delayed recognition score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Wechsler Memory Scale III (WMS-III) / Word Lists subtest, recognition (old-new) score after delay (range 0-24, higher score indicates better outcome), measures verbal memory & learning.
-
Change in the RBMT Story Recall subtest (immediate recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Rivermead Behavioural Memory Test (RBMT) / Story Recall subtest, immediate recall score (range 0-42, higher score indicates better outcome), measures episodic memory
-
Change in the RBMT Story Recall subtest (immediate recognition score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Rivermead Behavioural Memory Test (RBMT) / Story Recall subtest, recognition (old-new) score after immediate recall (range 0-12, higher score indicates better outcome), measures episodic memory.
-
Change in the RBMT Story Recall subtest (delayed recall score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Rivermead Behavioural Memory Test (RBMT) / Story Recall subtest, delayed recall score (range 0-42, higher score indicates better outcome), measures episodic memory.
-
Change in the RBMT Story Recall subtest (delayed recognition score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Rivermead Behavioural Memory Test (RBMT) / Story Recall subtest, recognition (old-new) score after delay (range 0-12, higher score indicates better outcome), measures episodic memory.
-
Change in the BIT Star Cancellation subtest (left side score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Behavioral Inattention Test (BIT) / Star Cancellation subtest, number of correctly marked items on the left side (range 0-27, higher score indicates better outcome), measures spatial attention (unilateral spatial neglect)
-
Change in the BIT Star Cancellation subtest (right side score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Behavioral Inattention Test (BIT) / Star Cancellation subtest, number of correctly marked items on the right side (range 0-27, higher score indicates better outcome), measures spatial attention (unilateral spatial neglect)
-
Change in the BIT Star Cancellation subtest (laterality index) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Behavioral Inattention Test (BIT) / Star Cancellation subtest, ratio of correctly marked items on the left side to total correctly marked items (range 0-1, lower score indicates better outcome), measures spatial attention (unilateral spatial neglect)
-
Change in the BIT Star Cancellation subtest (total score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Behavioral Inattention Test (BIT) / Star Cancellation subtest, number of correctly marked items (range 0-54, higher score indicates better outcome), measures spatial attention (unilateral spatial neglect)
-
Change in the WAB Conversational Question subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Conversational Question subtest, score (range 0-6, higher score indicates better outcome), measures spontaneous speech production.
-
Change in the WAB Conversational Question & Picture Description subtests (information content score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Conversational Question & Picture Description subtests, information content score (range 0-10, higher score indicates better outcome), measures spontaneous speech production
-
Change in the WAB Conversational Question & Picture Description subtests (fluency of speech score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Conversational Question & Picture Description subtests, fluency of speech score (range 0-10, higher score indicates better outcome), measures spontaneous speech production.
-
Change in the WAB Spontaneous speech score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Spontaneous speech score (sum of information content and fluency of speech scores; range 0-20, higher score indicates better outcome), measures spontaneous speech production.
-
Change in the WAB Conversational Question & Picture Description subtests (efficiency score) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Conversational Question & Picture Description subtests, number of correct information units per minute (min: 0, max: no fixed value, higher score indicates better outcome), measures spontaneous speech production.
-
Change in the WAB Repetition subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Repetition subtest, score (range: 0-100, higher score indicates better outcome), measures responsive speech production.
-
Change in the WAB Object Naming subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Object Naming subtest, score (range: 0-60, higher score indicates better outcome), measures responsive speech production.
-
Change in the WAB Word Fluency subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Word Fluency subtest, score (range: 0-20, higher score indicates better outcome), measures responsive speech production.
-
Change in the WAB Sentence Completion subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Sentence Completion subtest, score (range: 0-10, higher score indicates better outcome), measures responsive speech production.
-
Change in the WAB Responsive Speech subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Responsive Speech subtest, score (range: 0-10, higher score indicates better outcome), measures responsive speech production.
-
Change in the WAB Naming and Word Finding score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Naming and Word Finding score (sum of Object Naming, Word Fluency, Sentence Completion, Responsive Speech subtest scores; range: 0-100, higher score indicates better outcome), measures responsive speech production.
-
Change in the WAB Sequential Commands subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Western Aphasia Battery (WAB) / Sequential Commands subtest, score (range: 0-80, higher score indicates better outcome), measures verbal comprehension.
-
Change in the BDAE Verbal Agility subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Boston Diagnostic Aphasia Examination (BDAE) / Verbal Agility subtest, score (range: 0-14, higher score indicates better outcome), measures motor production of speech
-
Change in the BDAE Automatized Sequences subtest score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Boston Diagnostic Aphasia Examination (BDAE) / Automatized Sequences subtest, score (range: 0-8, higher score indicates better outcome), measures non-propositional speech.
-
Change in the ARAT Grasp subscale score (paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Grasp subscale score of the paretic hand (range: 0-18, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Grasp subscale score (non-paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Grasp subscale score of the non-paretic hand (range: 0-18, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Grip subscale score (paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Grip subscale score of the paretic hand (range: 0-12, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Grip subscale score (non-paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Grip subscale score of the non-paretic hand (range: 0-12, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Pinch subscale score (paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Pinch subscale score of the paretic hand (range: 0-18, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Pinch subscale score (non-paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Pinch subscale score of the non-paretic hand (range: 0-18, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Gross Movement subscale score (paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Gross Movement subscale score of the paretic hand (range: 0-9, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT Gross Movement subscale score (non-paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) / Gross Movement subscale score of the non-paretic hand (range: 0-9, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT total score (paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) total score of the paretic hand (range: 0-57, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT total score (non-paretic hand) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) total score of the non-paretic hand (range: 0-57, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the ARAT total score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Action Research Arm Test (ARAT) total score (both paretic & non-paretic hands; range: 0-114, higher score indicates better outcome), measures upper-extremity motor function.
-
Change in the BBT paretic hand score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Box and Block Test (BBT) total score for the paretic hand (range: 0-150, higher score indicates better outcome), measures gross manual dexterity.
-
Change in the BBT non-paretic hand score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Box and Block Test (BBT) total score for the non-paretic hand (range: 0-150, higher score indicates better outcome), measures gross manual dexterity.
-
Change in the BBT total score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Box and Block Test (BBT) total score for both hands (range: 0-300, higher score indicates better outcome), measures gross manual dexterity.
-
Change in the PPT paretic hand score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Purdue Pegboard Test (PPT) score of the paretic hand (range: 0-25, higher score indicates better outcome), measures fine manual dexterity.
-
Change in the PPT non-paretic hand score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Purdue Pegboard Test (PPT) score of the non-paretic hand (range: 0-25, higher score indicates better outcome), measures fine manual dexterity.
-
Change in the PPT both hands score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Purdue Pegboard Test (PPT) score of both hands (range: 0-25, higher score indicates better outcome), measures fine manual dexterity.
-
Change in the PPT total score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Purdue Pegboard Test (PPT) total score (range: 0-75, higher score indicates better outcome), measures fine manual dexterity.
-
Change in the PPT Assembly score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Purdue Pegboard Test (PPT) Assembly score (range: 0-80, higher score indicates better outcome), measures fine manual dexterity.
-
Change in PROMIS Depression subscale total score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Patient-Reported Outcomes Measurement Information System (PROMIS) / Depression subscale total score (patient self-report; range: 5-40, lower score indicates better outcome), measures depression.
-
Change in PROMIS Anxiety subscale total score from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Patient-Reported Outcomes Measurement Information System (PROMIS) / Anxiety subscale total score (patient self-report; range: 5-40, lower score indicates better outcome), measures anxiety.
-
Change in SIS Strength subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Strength subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures strength of the paretic upper-extremity.
-
Change in SIS Hand Function subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Hand Function subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures hand function of the paretic upper-extremity.
-
Change in SIS ADL subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / ADL subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures ability to perform activities of daily living.
-
Change in SIS Mobility subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Mobility subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures mobility in daily life.
-
Change in SIS Communication subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Communication subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures communication ability in daily life.
-
Change in SIS Emotion subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Emotion subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures mood.
-
Change in SIS Memory and Thinking subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Memory and Thinking subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures cognitive functioning in daily life.
-
Change in SIS Participation subscale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Participation subscale score (patient self-report; range: 0-100, higher score indicates better outcome), measures social interaction and involvement in life situations.
-
Change in SIS Recovery item score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Recovery item score (patient self-report using visual analogue scale, range: 0-100, higher score indicates better outcome), measures patient's perception of their overall recovery from stroke.
-
Change in SIS total score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) total score (patient self-report; range: 0-900, higher score indicates better outcome), measures overall quality of life after stroke.
-
Change in SIS Strength subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Strength subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures strength of the paretic upper-extremity.
-
Change in SIS Hand Function subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Hand Function subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures hand function of the paretic upper-extremity.
-
Change in SIS ADL subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / ADL subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures ability to perform activities of daily living.
-
Change in SIS Mobility subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Mobility subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures mobility in daily life.
-
Change in SIS Communication subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Communication subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures communication ability in daily life.
-
Change in SIS Emotion subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Emotion subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures mood.
-
Change in SIS Memory and Thinking subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Memory and Thinking subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures cognitive functioning in daily life.
-
Change in SIS Participation subscale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Participation subscale score (proxy report of family member; range: 0-100, higher score indicates better outcome), measures social interaction and involvement in life situations.
-
Change in SIS Recovery item score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) / Recovery item score (proxy report of family member using visual analogue scale, range: 0-100, higher score indicates better outcome), measures family member's perception of patient's overall recovery from stroke.
-
Change in SIS total score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Stroke Impact Scale (SIS) total score (proxy report of family member; range: 0-900, higher score indicates better outcome), measures overall quality of life after stroke.
-
Change in MAL total score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Motor Activity Log (MAL) total score (patient self-report; range: 0-70, higher score indicates better outcome), measures severity of upper-extremity paresis.
-
Change in MAL total score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Motor Activity Log (MAL) total score (proxy report of family member; range: 0-70, higher score indicates better outcome), measures severity of upper-extremity paresis.
-
Change in CAL Quantity of Communication scale score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Communicative Activity Log (CAL) / Quantity of Communication score (patient self-report; range: 0-90, higher score indicates better outcome), measures quantity of communication in daily life.
-
Change in CAL Quality of Communication score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Communicative Activity Log (CAL) / Quality of Communication scale score (patient self-report; range: 0-90, higher score indicates better outcome), measures quality of communication in daily life.
-
Change in CAL total score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Communicative Activity Log (CAL) total score (patient self-report; range: 0-180, higher score indicates better outcome), measures communication ability in daily life.
-
Change in CAL Quantity of Communication scale score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Communicative Activity Log (CAL) / Quantity of Communication score (proxy report of family member; range: 0-90, higher score indicates better outcome), measures quantity of communication in daily life.
-
Change in CAL Quality of Communication score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Communicative Activity Log (CAL) / Quality of Communication scale score (proxy report of family member; range: 0-90, higher score indicates better outcome), measures quality of communication in daily life.
-
Change in CAL total score (proxy report of family member) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Communicative Activity Log (CAL) total score (proxy report of family member; range: 0-180, higher score indicates better outcome), measures communication ability in daily life.
-
Change in CFQ total score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Cognitive Failures Questionnaire (CFQ) total score (patient self-report; range: 0-100, lower score indicates better outcome), measures severity of attention and executive deficits in daily life.
-
Change in PRMQ total score (patient self-report) from baseline to 3-month and 6-month stages
Time frame: Baseline, 3-month stage, and 6-month stage
Prospective and Retrospective Memory Questionnaire (PRMQ) total score (patient self-report; range: 5-80, higher score indicates better outcome), measures memory functioning in daily life.